OrthoPediatrics Statistics
Total Valuation
OrthoPediatrics has a market cap or net worth of $413.02 million. The enterprise value is $454.64 million.
Important Dates
The last earnings date was Tuesday, October 28, 2025, after market close.
| Earnings Date | Oct 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
OrthoPediatrics has 25.08 million shares outstanding. The number of shares has increased by 1.67% in one year.
| Current Share Class | 25.08M |
| Shares Outstanding | 25.08M |
| Shares Change (YoY) | +1.67% |
| Shares Change (QoQ) | +0.45% |
| Owned by Insiders (%) | 5.18% |
| Owned by Institutions (%) | 69.12% |
| Float | 16.88M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.69 |
| Forward PS | 1.51 |
| PB Ratio | 1.18 |
| P/TBV Ratio | 2.48 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.00 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.40, with a Debt / Equity ratio of 0.28.
| Current Ratio | 7.40 |
| Quick Ratio | 3.28 |
| Debt / Equity | 0.28 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.96 |
Financial Efficiency
Return on equity (ROE) is -12.67% and return on invested capital (ROIC) is -4.46%.
| Return on Equity (ROE) | -12.67% |
| Return on Assets (ROA) | -4.08% |
| Return on Invested Capital (ROIC) | -4.46% |
| Return on Capital Employed (ROCE) | -6.97% |
| Revenue Per Employee | $404,644 |
| Profits Per Employee | -$81,164 |
| Employee Count | 562 |
| Asset Turnover | 0.46 |
| Inventory Turnover | 0.51 |
Taxes
| Income Tax | -220,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -38.06% in the last 52 weeks. The beta is 1.02, so OrthoPediatrics's price volatility has been similar to the market average.
| Beta (5Y) | 1.02 |
| 52-Week Price Change | -38.06% |
| 50-Day Moving Average | 18.89 |
| 200-Day Moving Average | 21.67 |
| Relative Strength Index (RSI) | 35.33 |
| Average Volume (20 Days) | 244,251 |
Short Selling Information
The latest short interest is 1.08 million, so 4.31% of the outstanding shares have been sold short.
| Short Interest | 1.08M |
| Short Previous Month | 1.10M |
| Short % of Shares Out | 4.31% |
| Short % of Float | 6.40% |
| Short Ratio (days to cover) | 5.35 |
Income Statement
In the last 12 months, OrthoPediatrics had revenue of $227.41 million and -$45.61 million in losses. Loss per share was -$1.95.
| Revenue | 227.41M |
| Gross Profit | 163.12M |
| Operating Income | -32.06M |
| Pretax Income | -45.83M |
| Net Income | -45.61M |
| EBITDA | -12.55M |
| EBIT | -32.06M |
| Loss Per Share | -$1.95 |
Full Income StatementBalance Sheet
The company has $57.73 million in cash and $99.34 million in debt, giving a net cash position of -$41.61 million or -$1.66 per share.
| Cash & Cash Equivalents | 57.73M |
| Total Debt | 99.34M |
| Net Cash | -41.61M |
| Net Cash Per Share | -$1.66 |
| Equity (Book Value) | 349.31M |
| Book Value Per Share | 13.93 |
| Working Capital | 212.62M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$19.19 million and capital expenditures -$10.25 million, giving a free cash flow of -$29.44 million.
| Operating Cash Flow | -19.19M |
| Capital Expenditures | -10.25M |
| Free Cash Flow | -29.44M |
| FCF Per Share | -$1.17 |
Full Cash Flow StatementMargins
Gross margin is 71.73%, with operating and profit margins of -14.10% and -20.06%.
| Gross Margin | 71.73% |
| Operating Margin | -14.10% |
| Pretax Margin | -20.15% |
| Profit Margin | -20.06% |
| EBITDA Margin | -5.52% |
| EBIT Margin | -14.10% |
| FCF Margin | n/a |
Dividends & Yields
OrthoPediatrics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.67% |
| Shareholder Yield | -1.67% |
| Earnings Yield | -11.04% |
| FCF Yield | -7.13% |
Analyst Forecast
The average price target for OrthoPediatrics is $24.86, which is 50.94% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $24.86 |
| Price Target Difference | 50.94% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OrthoPediatrics has an Altman Z-Score of 2.35 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.35 |
| Piotroski F-Score | 3 |
